GSK Seeks Accelerated Approval for Proposed Avian Flu Vaccine

Drug Industry Daily
A A

British drugmaker GlaxoSmithKline (GSK) has joined the list of drug companies pursuing development of an avian flu vaccine, announcing late last week it plans to unveil initial clinical study results for its investigational vaccine in next year's second quarter.

To View This Article:

Login

Subscribe To Drug Industry Daily